This is an aggregated industry headline. Read the full story at FiercePharma →
Sanofi survey uncovers Type 1 diabetes misconceptions and screening gaps
Widespread misconceptions about Type 1 diabetes could be contributing to a reluctance to get screened for the autoimmune disease, according to a survey Sanofi commissioned.
By FiercePharma
· Jul 21, 2026
· via FiercePharma
RxInsider combines reported facts with industry analysis and informed inference. Forward-looking reads, market commentary, and interpretive framing reflect analysis of available reporting and known facts, not confirmed outcomes.
Tags
theweekformat:headlineheadlineFiercePharma
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from The Week
All The Week →
The WeekFierceBiotech ↗
Bristol Myers Squibb has entered into an expanded collaboration with Nvidia to create the biggest supercompute…
The WeekBriefing
Medicare’s proposal to trim hospital reimbursement for specific drugs and imaging services could extend site-n…
The WeekPharmaceutical Technology ↗
BMS enhances its AI computing power with NVIDIA's DGX SuperPOD as big pharma race to stay competitive within t…